These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16296755)

  • 1. Targeted delivery across the blood-brain barrier.
    Gaillard PJ; Visser CC; de Boer AG
    Expert Opin Drug Deliv; 2005 Mar; 2(2):299-309. PubMed ID: 16296755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
    Gaillard PJ; de Boer AG
    Methods Mol Biol; 2008; 437():161-75. PubMed ID: 18369968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes.
    Ito S; Ohtsuki S; Kamiie J; Nezu Y; Terasaki T
    J Neurochem; 2007 Dec; 103(6):2482-90. PubMed ID: 17908238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megalin binds and mediates cellular internalization of folate binding protein.
    Birn H; Zhai X; Holm J; Hansen SI; Jacobsen C; Christensen EI; Moestrup SK
    FEBS J; 2005 Sep; 272(17):4423-30. PubMed ID: 16128811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier.
    Hui EK; Boado RJ; Pardridge WM
    Mol Pharm; 2009; 6(5):1536-43. PubMed ID: 19624167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug targeting. Breaking down barriers.
    Miller G
    Science; 2002 Aug; 297(5584):1116-8. PubMed ID: 12183610
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of membrane transporters in drug delivery to brain tumors.
    Nies AT
    Cancer Lett; 2007 Aug; 254(1):11-29. PubMed ID: 17275180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake.
    Chung NS; Wasan KM
    Adv Drug Deliv Rev; 2004 May; 56(9):1315-34. PubMed ID: 15109771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway.
    Qian ZM; Li H; Sun H; Ho K
    Pharmacol Rev; 2002 Dec; 54(4):561-87. PubMed ID: 12429868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier after conjugation to anti-transferrin receptor antibodies.
    Walus LR; Pardridge WM; Starzyk RM; Friden PM
    J Pharmacol Exp Ther; 1996 May; 277(2):1067-75. PubMed ID: 8627518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier delivery.
    Pardridge WM
    Drug Discov Today; 2007 Jan; 12(1-2):54-61. PubMed ID: 17198973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cytoplasmic PPPSP motif determines megalin's phosphorylation and regulates receptor's recycling and surface expression.
    Yuseff MI; Farfan P; Bu G; Marzolo MP
    Traffic; 2007 Sep; 8(9):1215-30. PubMed ID: 17555532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy for effective brain drug delivery.
    Alam MI; Beg S; Samad A; Baboota S; Kohli K; Ali J; Ahuja A; Akbar M
    Eur J Pharm Sci; 2010 Aug; 40(5):385-403. PubMed ID: 20497904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endocytosis mediated by receptors--function and participation in oral drug delivery].
    Zuwała-Jagiełło J
    Postepy Hig Med Dosw; 2003; 57(3):275-91. PubMed ID: 14524247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of fusion proteins containing transferrin and nerve growth factor.
    Park E; Starzyk RM; McGrath JP; Lee T; George J; Schutz AJ; Lynch P; Putney SD
    J Drug Target; 1998; 6(1):53-64. PubMed ID: 9769021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of peptides, proteins, and genes by receptor-mediated endocytosis.
    Kato Y; Sugiyama Y
    Crit Rev Ther Drug Carrier Syst; 1997; 14(3):287-331. PubMed ID: 9282268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro.
    Candela P; Gosselet F; Miller F; Buee-Scherrer V; Torpier G; Cecchelli R; Fenart L
    Endothelium; 2008; 15(5-6):254-64. PubMed ID: 19065317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megalin mediates the transport of leptin across the blood-CSF barrier.
    Dietrich MO; Spuch C; Antequera D; Rodal I; de Yébenes JG; Molina JA; Bermejo F; Carro E
    Neurobiol Aging; 2008 Jun; 29(6):902-12. PubMed ID: 17324488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.